Clear Street’s Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 CMRAW Stock Holding History

Clear Street’s Portfolio CMRAW Stock Details CMRAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-30,100	Closed	-$90	–	997
2023 Q4	$90	Buy	30,100 +100	+0.3%	+$2	﹤0.01%	764
2023 Q3	$651	Hold	30,000	–	–	﹤0.01%	931
2023 Q2	$813	Hold	30,000	–	–	﹤0.01%	1092
2023 Q1	$1.29K	Hold	30,000	–	–	﹤0.01%	921
2022 Q4	$1K	Hold	30,000	–	–	﹤0.01%	983
2022 Q3	$2K	Hold	30,000	–	–	﹤0.01%	978
2022 Q2	$4K	Buy	+30,000	New	+$4.91K	﹤0.01%	760

Clear Street's CMRAW Position: Q1 2024 in Review

Clear Street sold out of Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 (CMRAW) in Q1 2024, closing a stake of 30,100 shares — an estimated $90 sold.

Clear Street first reported a position in CMRAW in Q2 2022 and held it in 7 quarters. The position peaked at $4K in Q2 2022. 0 funds tracked by Wall St. Rank hold CMRAW as of Q1 2024.

Clear Street reported no remaining Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 position as of Q1 2024 after selling out during the quarter.
Clear Street sold 30,100 Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 shares in Q1 2024, an estimated $90.
Clear Street first reported a position in Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 in Q2 2022 and held it in 7 quarters.
Clear Street's Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 position peaked at $4K in Q2 2022.
0 funds tracked by Wall St. Rank held Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 as of Q1 2024.

Based on Clear Street's 13F filing for Q1 2024, filed 13 May 2024.